CME vs TW: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CME and TW share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CME and TW exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

CME Group operates the largest futures and options marketplace in the world, spanning six asset classes: interest rates, equity indexes, energy, agricultural commodities, metals and foreign exchange. It earns money mainly from clearing and transaction fees charged on every contract traded and cleared, plus market-data and information-services revenue, and it benefits from owning both the exchange and the clearinghouse that guarantees trades. Volumes rise with hedging demand and market volatility, which is why record average daily volume has been the main engine of recent results.

Full CME guide

Tradeweb Markets operates electronic marketplaces that connect institutional, wholesale, and retail participants across rates, credit, equities, and money markets. The platform handles U.S. Treasuries, corporate and municipal bonds, interest rate swaps, ETFs, repo, and commercial paper, and it earns money largely through transaction and subscription fees that scale with trading volume. Roughly 90 percent-plus of revenue is recurring or volume-linked, and the business benefits from network effects: more liquidity draws more participants, which deepens liquidity further.

Full TW guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CME drivers: Record trading volumes; Interest-rate and volatility franchise.
• TW drivers: Structural electronification of fixed income; International and asset-class expansion.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees. For TW, tradeweb's premium valuation (a trailing P/E around 26) leaves limited margin for error if volume growth or fee capture disappoints.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CME if you believe its drivers more; TW if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CME and TW guides.

CME. CME posted record FY2025 revenue of about $6.5 billion and net income near $4.1 billion, then opened 2026 with record Q1 revenue of roughly $1.88 billion, up 14 percent, and adjusted EPS of $3.36. The shares trade around $240 for a market cap near $87 billion, a trailing P/E of roughly 21, with a high blended dividend yield reflecting the regular-plus-variable payout structure.

TW. Tradeweb trades at a growth-stock multiple relative to most financial exchanges, reflecting its double-digit organic growth, high margins, and strong cash conversion. Free cash flow topped $1 billion on a trailing basis, funding a rising dividend. Analyst price targets have ranged widely (roughly $111 on the low end to about $203 on the high end), underscoring disagreement about how much future electronification is already priced in.

Headline figures (approximate, JULY 2026): CME shows revenue (ttm) ~$6.7B, fy2025 revenue ~$6.5B, net income (ttm) ~$4.2B, market cap ~$87B; TW shows revenue (ttm) ~$2.2B, q1 2026 revenue ~$617.8M (up ~21% YoY), net income (ttm) ~$869M, adjusted ebitda margin ~55%.

CME and TW are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CME and TW exposure against your real portfolio. It is not an investment adviser.